Skip to content
January 30, 2025

Equity.Guru

Investment information for the new generation

Search
Latest News

Three Minute Hits

17 February 2023
Is Standard Uranium (STND.V) a long-term investment opportunity?
Standard Uranium (STND.V) has an interesting story, but traders may be casting a side eye over the recent downtrend in share price. Is this a legitimate concern? Equity Guru…
13 February 2023
SYH.V, AAZ.V, STND.V are the uranium superfriends
Uranium is in the spotlight as the fuel for the only reasonable option for base power as we transition into the age of green energy. Equity Guru founder, Chris…
8 February 2023
Parry’s first weed client in five years: BC Bud Corp…
In 2018, Equity Guru founder, Chris Parry, called the marijuana market crash four days before it happened. It’s been a brutal bloodletting since, with many unfortunate investors taking a…
7 February 2023
Medexus Pharma (MDP.T) is an arbitrage in the making
*originally published January 24, 2023 Medexus Pharmaceuticals (MDP.T) is a Canadian specialty pharma company servicing the North American market. The company has developed a robust portfolio of orphan drugs…
31 January 2023
Tiidal Gaming Group (TIDL.C) – Three Minute Hits Video
*originally published 08/24/22 Chris Parry, Equity.Guru founder, discusses Tiidal Gaming Group (TIDL.C), a Canadian-based esports and gaming platform focused on acquiring and operating synergistic media and technology companies within…
26 January 2023
Azincourt Energy (AAZ.V) digging for value
*originally published 08-06-2022 Equity.Guru founder, Chris Parry, discusses Azincourt Energy (AAZ.V), a Canadian junior with highly prospective uranium properties in the storied Athabasca Basin. Enjoy!…
24 January 2023
Should I invest in crypto? No, you should not.
Cryptocurrency was all the rage, but now it seems the enthusiasm is fading as the digital asset class continues to fail to produce real long-lasting value that isn’t based…
16 January 2023
Why is this stock such a dumpster fire?
Modern Plant Based Foods (MEAT.C) went from next to nothing to $100 million in the space of a month powered by the names who brought you the Bridgemark scandal….
16 January 2023
This specialty pharma stock trades at one-third of annual revenue,…
Medexus Pharmaceuticals (MDP.T), a Canadian specialty pharma company focused on the North American markets, has developed a robust drug portfolio that still has lots of room for growth. Due…
16 December 2022
Was Northern Lights (NLR.C) right in selling Medicine Springs to…
Northern Lights Resources (NLR.C), a Canadian-based mineral explorer developing assets in Nevada and Arizona, made a short term kill when it sold its 25% interest in Medicine Springs, a…